Johnson & Johnson closes $19.7-billion acquisition of Synthes, Inc.

New Brunswick, NJ—Pharmaceutical giant Johnson & Johnson has closed a $19.7-billion deal to acquire orthopedics firm Synthes, Inc.

According to the company’s website, Synthes develops, produces and markets instruments, implants and biomaterials for the surgical correction, fixation and regeneration of the skeleton and its soft tissues.

Synthes will now be integrated with the DePuy franchise to establish the DePuy Synthes Companies of Johnson & Johnson.